non-evidence based, or off-label, prescribing which has fueled testosterone use over the previous decade, according to IMS Health sales data. The FDA aims to curb overprescribing by doctors, and the associated potential increased risk of heart attacks
On the IPO front, the quarter saw the debut of, among others, Ally Financial ALLY, GoPro GPRO, JD.com JD, and IMS Health IMS. The notable S-1 filings in the quarter included Chinese e-commerce giant Alibaba and GoDaddy. Sector-by-Sector
(Reuters) - Shares of TPG Capital Management-backed IMS Health Holdings Inc rose as much as 14 percent in their trading debut, valuing the healthcare information company at up to $7.55 billion.
April 3 (Reuters) - IMS Health Holdings Inc, TPG Capital Management-backed healthcare information company, said its initial public offering was priced at $20 per share, valuing the company at about...
IMS Health is on the right track for growth.
NEW YORK, Dec 17 (Reuters) - IMS Health Inc has hired JPMorgan Chase & Co Inc to lead a proposed initial public offering that could value the private equity-owned healthcare information company at...
heating up in the emerging nations. The emerging nations currently account for 20% of all drug sales, according to IMS Health . And it’s forecast that drug sales there will rise 85% by 2016, to $359 billion from $194 billion in 2011
Raymond H. Hill joined PPD as chief executive officer and a member of the board last week. He previously was president of IMS Health 's Consulting Group, which is a leading health-care industry consultant. Hill's experience as a consultant in
NEW YORK (Reuters) - Spending growth on prescription drugs slowed to 2.3 percent in 2010 -- the second lowest level in 55 years, according to a report by IMS Health .
leader with a nearly 20% gain. A wide range of software firms led the sector to strong gains in the quarter, including IMS Health RX (+38%), Wipro WIT (+25%), and Salesforce.com CRM (+30). The market is betting that improved corporate